Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV

被引：11
|
作者：
Liu, Tao [1 ]
Weng, Zhiyong [1 ]
Dong, Xiaowu [1 ]
Hu, Yongzhou [1 ]
机构：
[1] Zhejiang Univ, Coll Pharmaceut Sci, ZJU ENS Joint Lab Med Chem, Hangzhou 310058, Zhejiang, Peoples R China
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2010年 / 10卷 / 13期
关键词：
HIV; Entry; Co-receptor; CCR5; Small-molecule inhibitor; Maraviroc; IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR ANTAGONISTS; INFECTION IN-VITRO; BIOLOGICAL EVALUATION; ANTI-HIV-1; AGENTS; HIGHLY POTENT; ANTIVIRAL ACTIVITY; ENTRY INHIBITORS; VIRAL ENTRY; PART;
D O I：
10.2174/13895575110091277
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
CCR5 (C-C chemokine receptor type 5) is a chemokine receptor that has been identified as a major HIV coreceptor in viral entry and therefore is a highly validated target for the development of new anti-HIV drugs. Here, we discuss the insights gained so far relevant to the development of small-molecule CCR5 inhibitors for the treatment of HIV, and highlight small-molecule CCR5 inhibitors that are currently under preclinical and clinical trials.
引用
收藏
页码：1277 / 1292
页数：16
相关论文
共 50 条
  • [31] Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1
    Murga, Jose D.
    Franti, Michael
    Pevear, Daniel C.
    Maddon, Paul J.
    Olson, William C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3289 - 3296
  • [32] Recent Advances on Small-Molecule Bromodomain-Containing Histone Acetyltransferase Inhibitors
    Liu, Mingxia
    Zhang, Kaiyao
    Li, Qinjue
    Pang, Haiying
    Pan, Zhaoping
    Huang, Xiaowei
    Wang, Lian
    Wu, Fengbo
    He, Gu
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (03) : 1678 - 1699
  • [33] Small-molecule MDM2-p53 inhibitors: recent advances
    Zhang, Bian
    Golding, Bernard T.
    Hardcastle, Ian R.
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (05) : 631 - 645
  • [34] C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors
    Hu, Qinxue
    Huang, Xin
    Shattock, Robin J.
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 2965 - 2973
  • [35] Recent Advances in Small-Molecule Modulation of Epigenetic Targets: Discovery and Development of Histone Methyltransferase and Bromodomain Inhibitors
    Sweis, Ramzi F.
    Michaelides, Michael R.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 185 - 203
  • [36] Small-molecule antagonists of CCR5 and CXCR4: A promising new class of anti-HIV-1 drugs
    Seibert, C
    Sakmar, TP
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (17) : 2041 - 2062
  • [37] A V3-independent pathway to resistance to small molecule CCR5 inhibitors
    Anastasopoulou, Dr. Kleio
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 27 - 27
  • [38] CCR5 Small Molecule Inhibitors Reduce Invasion And Migration Of Lung Adenocarcinoma Cells
    Kim, H.
    Quezada, W.
    Qu, A.
    Stasik, K.
    Zwack, E.
    Zhao, W.
    Toonkel, R. L.
    Borczuk, A. C.
    Powell, C. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [39] Small Molecule Antagonists of the Chemokine Receptor CCR5
    Lemoine, Remy C.
    Wanner, Jutta
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (13) : 1299 - 1338
  • [40] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
12345